121 related articles for article (PubMed ID: 2185880)
1. Amplification of the c-myc oncogene during progression of radiation-induced rat skin tumors.
Garte SJ; Burns FJ; Ashkenazi-Kimmel T; Felber M; Sawey MJ
Cancer Res; 1990 May; 50(10):3073-7. PubMed ID: 2185880
[TBL] [Abstract][Full Text] [Related]
2. Oncogene amplification detected by in situ hybridization in radiation-induced skin cancers in rats.
Jin Y; Burns FJ; Garte SJ
Radiat Res; 1992 Nov; 132(2):193-9. PubMed ID: 1438701
[TBL] [Abstract][Full Text] [Related]
3. Amplification of the c-myc oncogene in radiation-induced rat skin tumors as a function of linear energy transfer and dose.
Felber M; Burns FJ; Garte SJ
Radiat Res; 1992 Sep; 131(3):297-301. PubMed ID: 1438687
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
6. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
Ocadiz R; Sauceda R; Cruz M; Graef AM; Gariglio P
Cancer Res; 1987 Aug; 47(15):4173-7. PubMed ID: 3300961
[TBL] [Abstract][Full Text] [Related]
7. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
Gaffey MJ; Frierson HF; Williams ME
Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
[TBL] [Abstract][Full Text] [Related]
9. Amplification and rearrangement of c-myc in radiation-induced murine osteosarcomas.
Sturm SA; Strauss PG; Adolph S; Hameister H; Erfle V
Cancer Res; 1990 Jul; 50(13):4146-53. PubMed ID: 2141296
[TBL] [Abstract][Full Text] [Related]
10. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA
Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785
[TBL] [Abstract][Full Text] [Related]
11. Activation of c-myc and c-K-ras oncogenes in primary rat tumors induced by ionizing radiation.
Sawey MJ; Hood AT; Burns FJ; Garte SJ
Mol Cell Biol; 1987 Feb; 7(2):932-5. PubMed ID: 3547086
[TBL] [Abstract][Full Text] [Related]
12. An experimental model for oncogene activation during tumor progression in vivo.
Garte SJ; Burns FJ; Ashkenazi-Kimmel T; Cosma GN; Sawey MJ
Anticancer Res; 1989; 9(5):1439-46. PubMed ID: 2686538
[TBL] [Abstract][Full Text] [Related]
13. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro.
Suchy BK; Sarafoff M; Kerler R; Rabes HM
Cancer Res; 1989 Dec; 49(23):6781-7. PubMed ID: 2684400
[TBL] [Abstract][Full Text] [Related]
14. Expression of cellular oncogenes: unrearranged c-myc gene but altered promoter usage in radiation-induced thymoma.
Bandyopadhyay SK; D'Andrea E; Fleissner E
Oncogene Res; 1989; 4(4):311-8. PubMed ID: 2475843
[TBL] [Abstract][Full Text] [Related]
15. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.
Bigner SH; Friedman HS; Vogelstein B; Oakes WJ; Bigner DD
Cancer Res; 1990 Apr; 50(8):2347-50. PubMed ID: 2180567
[TBL] [Abstract][Full Text] [Related]
16. Specificity of proto-oncogene amplification in human malignant diseases.
Masuda H; Battifora H; Yokota J; Meltzer S; Cline MJ
Mol Biol Med; 1987 Aug; 4(4):213-27. PubMed ID: 3670047
[TBL] [Abstract][Full Text] [Related]
17. C-myc proto-oncogene amplification detected by polymerase chain reaction in archival human ovarian carcinomas.
Schreiber G; Dubeau L
Am J Pathol; 1990 Sep; 137(3):653-8. PubMed ID: 2205100
[TBL] [Abstract][Full Text] [Related]
18. Tumorigenicity of SEWA murine cells correlates with degree of c-myc amplification.
Martinsson T; Ståhl F; Pollwein P; Wenzel A; Levan A; Schwab M; Levan G
Oncogene; 1988 Oct; 3(4):437-41. PubMed ID: 3078951
[TBL] [Abstract][Full Text] [Related]
19. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
[TBL] [Abstract][Full Text] [Related]
20. The c-myc oncogene in tumor progression.
Garte SJ
Crit Rev Oncog; 1993; 4(4):435-49. PubMed ID: 8353142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
